Abiopharma

IOI Corporation Berhad, an investment holding company, primarily engages in the plantation business in Malaysia, Europe, North America, Asia, and internationally. The company operates through two segments, Plantation and Resource-Based Manufacturing. It cultivates oil palm, softwood timber, rubber, and coconut; refines and processes crude palm, crude coconut, and palm kernel oils; and manufactures specialty oils and fats. The company also manufactures and exports fatty acids, soap noodles, glycerin, fatty esters, and other related products. In addition, it is involved in the commercialization of clonal ramets and biotechnology related research and development activities; provision of management and marketing services; production and supply of palm-based renewable energy; and trading of palm oil commodities, oilseeds, and edible oils and fats; and the processing of raw materials for the edible oils and fats industry. Further, the company engages in the property development, maintenance, and investment activities; issuance of exchangeable bonds and guaranteed notes; processing of oil palm trunks; storage tanks rental activities; manufacturing of oleochemical products; and provision of bulk cargo warehousing services, as well as treasury management services and management consulting services. Additionally, it is involved in the manufacture and sale of pharmaceutical products, plasticizer products, margarine, and shortening and fat spreads; manufacture of palm wood boards and panels under OnCore brand name used in furniture, construction, and building industries; and development of proprietary keto-ester portfolio.

Additional info from OTC:
IOI Corporation Berhad, an investment holding company, primarily engages in the plantation business in Malaysia, Europe, North America, Asia, and internationally. The company operates through two segments, Plantation and Resource-Based Manufacturing. It cultivates oil palm, softwood timber, rubber, and coconut; refines and processes crude palm, crude coconut, and palm kernel oils; and manufactures specialty oils and fats. The company also manufactures and exports fatty acids, soap noodles, glycerin, fatty esters, and other related products. In addition, it is involved in the commercialization of clonal ramets and biotechnology related research and development activities; provision of management and marketing services; production and supply of palm-based renewable energy; and trading of palm oil commodities, oilseeds, and edible oils and fats; and the processing of raw materials for the edible oils and fats industry. Further, the company engages in the property development, maintenance, and investment activities; issuance of exchangeable bonds and guaranteed notes; processing of oil palm trunks; storage tanks rental activities; manufacturing of oleochemical products; and provision of bulk cargo warehousing services, as well as treasury management services and management consulting services. Additionally, it is involved in the manufacture and sale of pharmaceutical products, plasticizer products, margarine, and shortening and fat spreads; manufacture of palm wood boards and panels under OnCore brand name used in furniture, construction, and building industries; and development of proprietary keto-ester portfolio.